State Street Corp Aclaris Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 188,721 shares of ACRS stock, worth $747,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188,721

Previous 196,621 4.02%

Holding current value

$747,335

Previous $216,000 1.39%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.4 $8,848 - $11,060	-7,900 Reduced 4.02%	188,721 $213,000
Q2 2024 Aug 14, 2024	SELL	$1.01 - $1.36 $1.15 Million - $1.55 Million	-1,141,818 Reduced 85.31%	196,621 $216,000
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $46,000 - $72,000	-50,000 Reduced 3.6%	1,338,439 $1.66 Million
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $111,404 - $1.13 Million	-174,069 Reduced 11.14%	1,388,439 $1.46 Million
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $725,037 - $1.21 Million	110,524 Added 7.61%	1,562,508 $10.7 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $225,890 - $304,623	28,630 Added 2.01%	1,451,984 $15.1 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $848,569 - $2.15 Million	120,024 Added 9.21%	1,423,354 $11.5 Million
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $4,341 - $5,566	303 Added 0.02%	1,303,330 $20.5 Million
Q3 2022 Nov 15, 2022	BUY	$13.07 - $18.22 $951,313 - $1.33 Million	72,786 Added 5.92%	1,303,027 $20.5 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $1.49 Million - $2.51 Million	146,851 Added 13.55%	1,230,241 $17.2 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $350,640 - $645,120	36,000 Added 3.44%	1,083,390 $18.7 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $132,196 - $199,211	-10,774 Reduced 1.02%	1,047,390 $15.2 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $161,229 - $226,540	-12,050 Reduced 1.13%	1,058,164 $19 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $15 Million - $26 Million	877,272 Added 454.68%	1,070,214 $18.8 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $673,325 - $3.19 Million	114,902 Added 147.23%	192,942 $4.86 Million
Q2 2020 Aug 14, 2020	SELL	$1.04 - $1.73 $612,713 - $1.02 Million	-589,148 Reduced 88.3%	78,040 $126,000
Q1 2020 May 11, 2020	BUY	$0.75 - $2.18 $500,391 - $1.45 Million	667,188 New	667,188 $694,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $264M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Aclaris Therapeutics, Inc. Transaction History